Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001178913-13-001560)

Filing Details

Accession Number:: 0001178913-13-001560
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-21 09:35:07
Reporting Period:: 2013-05-16

Filing Date:: 2013-05-21
Accepted Time:: 2013-05-21 09:35:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158780	Pluristem Therapeutics Inc	PSTI	Biological Products, (No Disgnostic Substances) (2836)	980351734

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1320556	Israel Ben-Yoram	24 Barkan Street Rishon Lezion L3 75436		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-05-16	21,500	$3.06	298,708	No	4	S	Direct
Common Stock	Acquisiton	2013-05-16	13,902	$3.00	312,610	No	4	P	Direct
Common Stock	Acquisiton	2013-05-16	50,000	$3.05	362,610	No	4	P	Direct
Common Stock	Disposition	2013-05-17	18,800	$3.01	343,810	No	4	S	Direct
Common Stock	Disposition	2013-05-20	5,129	$3.01	338,681	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	P	Direct
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The reporting person sold the issuer's securities in connection with a process of transferring the securities from a trustee account to the reporting person's personal account. The reporting person has submitted payment to the issuer to disgorge profits he realized from these trades in accordance with Section 16(b) of the Securities Exchange Act.